131 related articles for article (PubMed ID: 3010070)
1. Human T-lymphotropic virus type III/lymphadenopathy-associated virus antibody testing at alternate sites.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1986 May; 35(17):284-7. PubMed ID: 3010070
[TBL] [Abstract][Full Text] [Related]
2. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822
[TBL] [Abstract][Full Text] [Related]
3. Update: Public Health Service workshop on human T-lymphotropic virus type III antibody testing--United States.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1985 Aug; 34(31):477-8. PubMed ID: 2991728
[TBL] [Abstract][Full Text] [Related]
4. Recommendations for providing dialysis treatment to patients infected with human T-lymphotropic virus type III/lymphadenopathy-associated virus. Centers for Disease Control, Department of Health and Human Services.
Ann Intern Med; 1986 Oct; 105(4):558-9. PubMed ID: 3019202
[TBL] [Abstract][Full Text] [Related]
5. Assessment of screening as a preventive technology: the example of HTLV-III/LAV antibody testing.
Ory HW; Koplan JP; Allen JR
Isr J Med Sci; 1986; 22(7-8):524-8. PubMed ID: 3640749
[TBL] [Abstract][Full Text] [Related]
6. Human T-lymphotropic virus type III/lymphadenopathy-associated virus: agent summary statement.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1986 Aug; 35(34):540-2, 547-9. PubMed ID: 3018469
[No Abstract] [Full Text] [Related]
7. Immunization of children infected with human T-lymphotropic virus type III/lymphadenopathy-associated virus. Recommendations of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services.
Ann Intern Med; 1987 Jan; 106(1):75-8. PubMed ID: 3024547
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of HTLV-III/LAV antibody in selected populations in Thailand.
Wangroongsarb Y; Weniger BG; Wasi C; Traisupa A; Kunasol P; Rojanapithayakorn W; Fucharoen S
Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):517-20. PubMed ID: 3869739
[TBL] [Abstract][Full Text] [Related]
9. Transfusion-associated acquired immunodeficiency syndrome. Evidence for persistent infection in blood donors.
Feorino PM; Jaffe HW; Palmer E; Peterman TA; Francis DP; Kalyanaraman VS; Weinstein RA; Stoneburner RL; Alexander WJ; Raevsky C
N Engl J Med; 1985 May; 312(20):1293-6. PubMed ID: 2985992
[TBL] [Abstract][Full Text] [Related]
10. HTLV-III AIDS link.
Bennett JA
Am J Nurs; 1985 Oct; 85(10):1086-9. PubMed ID: 2996353
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
Yarchoan R; Redfield RR; Broder S
J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
[TBL] [Abstract][Full Text] [Related]
12. Tuberculosis--United States, 1985--and the possible impact of human T-lymphotropic virus type III/lymphadenopathy-associated virus infection.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1986 Feb; 35(5):74-6. PubMed ID: 3080659
[TBL] [Abstract][Full Text] [Related]
13. [Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type III (LAV/HTLV) in a population of homosexuals in Mexico].
Sierra Madero JG; Ponce de León S; Ruiz Palacios G; Tinoco JC; Calva JJ; Zamora EE
Salud Publica Mex; 1986; 28(2):180-5. PubMed ID: 3014666
[No Abstract] [Full Text] [Related]
14. Revision of the case definition of acquired immunodeficiency syndrome for national reporting--United States.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1985 Jun; 34(25):373-5. PubMed ID: 2989677
[TBL] [Abstract][Full Text] [Related]
15. Characteristics and trends of newly identified HIV infections among incarcerated populations: CDC HIV voluntary counseling, testing, and referral system, 1992-1998.
Sabin KM; Frey RL; Horsley R; Greby SM
J Urban Health; 2001 Jun; 78(2):241-55. PubMed ID: 11419578
[TBL] [Abstract][Full Text] [Related]
16. Revision of the case definition of acquired immunodeficiency syndrome for national reporting--United States. Centers for Disease Control, Department of Health and Human Services.
Ann Intern Med; 1985 Sep; 103(3):402-3. PubMed ID: 2992336
[TBL] [Abstract][Full Text] [Related]
17. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1986 May; 35(20):334-9. PubMed ID: 3010072
[TBL] [Abstract][Full Text] [Related]
18. The prospects for and pathways toward a vaccine for AIDS.
Francis DP; Petricciani JC
N Engl J Med; 1985 Dec; 313(25):1586-90. PubMed ID: 2999596
[TBL] [Abstract][Full Text] [Related]
19. Acquired immunodeficiency syndrome: meeting of the WHO Collaborating Centres on AIDS.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1985 Nov; 34(44):678-9. PubMed ID: 3932833
[TBL] [Abstract][Full Text] [Related]
20. Acquired immune deficiency syndrome (AIDS)--recommendations of IMAP.
International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
IPPF Med Bull; 1986 Jun; 20(3):3-4. PubMed ID: 12268332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
